REFERENCES
- H. Berman, K. Henrick, and H. Nakamura. (2003). Announcing the worldwide Protein Data Bank. Nat. Struct. Biol. 10 (12):980.
- Y. Garten, and R. B. Altman. (2008). Pharmspresso: a text mining tool for extraction of pharmacogenetics concepts and relationships from full text. 2008 AMIA Translational Bioinformatics Summit submitted.
- K. M. Giacomini, C. M. Brett, R. B. Altman, N. L. Benowitz, M. E. Dolan, D. A. Flockhart, and et al (2007). The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin. Pharmacol. Ther. 81 (3):328–345.
- M. P. Goetz, S. K. Knox, V. J. Suman, J. M. Rae, S. L. Safgren, M. M. Ames, and et al (2007). The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res. Treat. 101 (1):113–121.
- T. Hernandez-Boussard, M. Whirl-Carrillo, J. M. Hebert, L. Gong, R. Owen, M. Gong, and et al (2008). The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res. 36:D913–D918.
- M. Hirakawa, T. Tanaka, Y. Hashimoto, M. Kuroda, T. Takagi, and Y. Nakamura. (2002). Nucleic Acids Res. 30 (1):158–162.
- A. E. Hodge, R. B. Altman, and T. E. Klein. (2007). The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge. Clin. Pharmacol. Ther. 81 (1):21–24.
- V. C. Jordan. (2008). Tamoxifen: catalyst for the change to targeted therapy. Eur. J. Cancer 44 (1):30–38.
- D. Karolchik, R. M. Kuhn, R. Baertsch, G. P. Barber, H. Clawson, M. Diekhans, and et al (2008). The UCSC genome browser database: 2008 update. Nucleic Acids Res. 36:D773–D779.
- W. J. Kent, C. W. Sugnet, T. S. Furey, K. M. Roskin, T. H. Pringle, A. M. Zahler, and et al (2002). The human genome browser at UCSC. Gen. Res. 12 (6):996–1006.
- International Wafarin Pharmacogenetics Consortium. (2008). Global Warfarin Pharmacogenetic Dosing Algorithm submitted
- D. A. Lindberg, B. L. Humphreys, and A. T. McCray. (1993). The Unified Medical Language System. Meth. Inf. Med. 32:281–291.
- R. P. Owen, R. B. Altman, and T. E. Klein. (2008). PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum. Mutat. 29 (4):456–460.
- R. P. Owen, T. E. Klein, and R. B. Altman. (2007). The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB). Clin. Pharmacol. Ther. 82 (4):472–475.
- G. M. Poulter, D. L Rubin, R. B. Altman, and C. Seoighe. (2008). MScanner: a classifier for retrieving Medline citations. BMC Bioinform. 9:108.
- W. Schroth, L. Antoniadou, P. Fritz, M. Schwab, T. Muerdter, U. M. Zanger, and et al (2007). Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. J. Clin. Oncol. 25 (33):5187–5193.
- S. T. Sherry, M. H. Ward, M. Kholodov, J. Baker, L. Phan, E. M. Smigielski, and et al (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29 (1):308–311.
- H. M. Wain, E. A. Bruford, R. C. Lovering, M. J. Lush, M. W. Wright, and S. Povey. (2002). Guidelines for human gene nomenclature. Genomics 79 (4):464–470.